Evidence map›Paper›PMID 37046317›Full record

ArticleDiabetology & metabolic syndrome2023

The hypertension and hyperlipidemia status among type 2 diabetic patients in the community and influencing factors analysis of glycemic control.

Zhiyu Zhai, Yunou Yang, Guozhen Lin, Weiquan Lin, Jiagang Wu, Xiangyi Liu, Shijia Zhang, Qin Zhou, Hui Liu, Guang Hao

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhiyu ZhaiDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Yunou YangDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Guozhen LinDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Weiquan LinDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Jiagang WuDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Xiangyi LiuDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China.
Shijia ZhangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, 601 West Huangpu Road, Guangzhou, 510632, Guangdong, China.
Qin ZhouDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China. 273142563@qq.com.
Hui LiuDepartment of Non-Communicable Chronic Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, No. 1 Qide Road, Guangzhou, 510440, Guangdong, China. gzcdc_liuh@gz.gov.cn.
Guang HaoDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, 601 West Huangpu Road, Guangzhou, 510632, Guangdong, China. haoguang2015@hotmail.com.
Guangzhou Center for Disease Control and Prevention · CNJinan University · CN

Funding

Basic Research Project of Key Laboratory of Guangzhou 2021BRP004Key Project of Medicine Discipline of Guangzhou No.2021-2023-12
6 · The paper itself

Abstract

objectiveTo understand the prevalence of hypertension and hyperlipidaemia as well as the current status of glycaemic control and its influencing factors among type 2 diabetes mellitus patients in the community in South China, and to provide recommendations for the prevention and control of diabetes.

methodsQuestionnaires, physical examinations and laboratory tests were conducted on patients with type 2 diabetes mellitus who participated in the National Basic Public Health Service Programme in Guangzhou in 2020. The chi-square test, t-test and multi-factor unconditional logistic regression analysis were performed using R 4.1.2 software.

resultAmong 127,423 type 2 diabetic patients in Guangzhou, 57,695 achieved glycemic control standards, with a glycemic control rate of 45.28%.In this study, the proportion of T2DM patients with hypertension and hyperlipidaemia together was 27.79%, The percentage of T2DM patients with hypertension alone and hyperlipidaemia alone was 28.34% and 20.53% respectively, and the rate of no complications was 23.34%. There was a statistically significant difference in the rate of glycaemic control between the different disease combination states (P < 0.05). The glycaemic control rate was 47.67% in diabetic patients without hypertension and hyperlipidaemia, 52.54% and 37.24% in those with combined hypertension alone and hyperlipidaemia alone respectively, compared to 41.80% in diabetic patients with hypertension and hyperlipidaemia. After adjusting for all covariates, multivariate analysis showed that combined hypertension alone was associated with good glycaemic control (OR 0.817, 95% CI 0.791, 0.843, P < 0.001),when using comorbid T2DM as a control group, combined hyperlipidaemia alone, combined hypertension and hyperlipidaemia were associated with poor glycaemic control (OR 1.521, 95% CI 1.470,1.574, P < 0.001 and OR 1.250, 95% CI 1.211,1.291, P < 0.001), Subgroup analyses as well as multifactorial unconditional logistic regression analyses showed that patients with type 2 diabetes who were overweight and obese, smoked, drank alcohol, had a diagnosis of diabetes for ≥ 6 years, had fair or poor adherence and had a family history of diabetes had lower rates of glycaemic control.

conclusionThe results of this study showed that the co-morbidity of hypertension and hyperlipidaemia was high and prevalent among diabetic patients in Guangzhou. Moreover, glycaemic control of T2DM patients with hyperlipidaemia was lower than other diabetic patients. Obesity and overweight, poor lifestyle and dietary habits are also major factors affecting the treatment and control of T2D patients in this region. Therefore, comprehensive measures should be actively taken to control blood glucose levels in type 2 diabetic patients by also incorporating lipid management into the community and strictly controlling lipid levels.

Indexed as

Blood glucose controlDiabetesHyperlipidemiaHypertension

Identifiers

PMID37046317
PMCPMC10100166
OpenAlexW4365137052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.